Oxiplex is designed to be used during lumbar spine surgery. It’s a viscoelastic gel and has been sold in Europe since 2001. FzioMed has been striving since then to get U.S. market approval.
During a special Medical Device Dispute Resolution Panel, the FDA approved the company’s petition for an independent review after an earlier agency denial of the gel.
More Articles on Devices:
Zimmer Spine Launches Viewline MIS Instruments
Roberto Quarta to Serve as Smith & Nephew’s New Chairman
AxoGen Profits Up 60% in Q3 to $2.31M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
